Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit MelanomaRyan S. Turley, Douglas S. Tyler, Andrew N. Fontanella et al.|Clinical Cancer Research|2012Cited by 57
Supplementary Figure 1 from Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit MelanomaRyan S. Turley, Douglas S. Tyler, Andrew N. Fontanella et al.|Unknown|2023Cited by 0
Supplementary Figure 2 from Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit MelanomaRyan S. Turley, Douglas S. Tyler, Andrew N. Fontanella et al.|Unknown|2023Cited by 0
Supplementary Figure Legend from Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit MelanomaRyan S. Turley, Douglas S. Tyler, Andrew N. Fontanella et al.|Unknown|2023Cited by 0
Data from Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit MelanomaRyan S. Turley, Douglas S. Tyler, Andrew N. Fontanella et al.|Unknown|2023Cited by 0